{"contacts": [{"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Edouard Louis"}, {"accession": "MS:1000589", "name": "contact email", "value": "edouard.Louis@uliege.be"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Laboratory of Translational Gastroenterology, GIGA-institute, University of Li\u00e8ge"}]}, {"terms": [{"accession": "MS:1002037", "name": "dataset submitter"}, {"accession": "MS:1000586", "name": "contact name", "value": "Nicolas Pierre"}, {"accession": "MS:1000589", "name": "contact email", "value": "nicolas.pierre@uliege.be"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Laboratory of Translational Gastroenterology, GIGA-institute, University of Li\u00e8ge, Li\u00e8ge, Belgium"}]}], "description": "Conclusion: We identified for the first time circulating biomarker candidates associated with the risk of long-term relapse in CD patients stopping infliximab. We also highlight a sequence of pathophysiological processes leading to relapse, this could help to better understand the disease progression. Our findings may pave the way for a better non-invasive evaluation of the risk of relapse when contemplating anti-TNF\u03b1 withdrawal in CD patients.", "fullDatasetLinks": [{"accession": "MS:1002873", "name": "Panorama Public dataset URI", "value": "https://panoramaweb.org/atQBcH.url"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD019434"}, {"accession": "MS:1001921", "name": "ProteomeXchange accession number version number", "value": "1"}, {"accession": "MS:1002872", "name": "Panorama Public dataset identifier", "value": "https://panoramaweb.org/atQBcH.url"}], "instruments": [{"accession": "MS:1001792", "name": "Xevo TQ-S"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Crohn's disease"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "biomarkers"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "relapse"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "selected reaction monitoring"}], "modifications": [{"accession": "UNIMOD:4", "name": "Carbamidomethyl"}, {"accession": "UNIMOD:259", "name": "Label:13C(6)15N(2)"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "33106355"}, {"accession": "MS:1002866", "name": "Reference", "value": "Pierre N, Baiwir D, Huynh-Thu VA, Mazzucchelli G, Smargiasso N, De Pauw E, Bouhnik Y, Laharie D, Colombel JF, Meuwis MA, Louis E; GETAID (Groupe d'Etude Th\u00e9rapeutique des Affections Inflammatoires du tube Digestif). Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn's patients: a proteomics-based study. Gut. 2020 Oct 26:gutjnl-2020-322100. doi: 10.1136/gutjnl-2020-322100. Epub ahead of print. PMID: 33106355."}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Discovery of biomarker candidates associated with the risk of short- and long-term relapse after infliximab withdrawal in Crohn\u2019s patients: a proteomics-based study"}